Business10 years ago
Notable Buzz: Merrimack Pharmaceuticals Inc (NASDAQ:MACK), Insys Therapeutics Inc(NASDAQ:INSY), Brixmor Property Group Inc(NYSE:BRX)
Merrimack Pharmaceuticals Inc(NASDAQ:MACK) has its tail in the air after “encouraging clinical data” from the expanded Phase 1 study of MM-302 for treatment of advanced HER2-positive...